Akebia Therapeutics, Inc.

AKBA

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001517022

SEC filings (opens in a new tab)

No open-market purchases or sales by Akebia Therapeutics, Inc. insiders were filed in the last 90 days; 170 institutions reported holding it in 13F filings for Q2 2026, worth $123.2M in total; no superinvestor holds it.

Q4 2021 vs. Q3 2021

How the institutions holding Akebia Therapeutics, Inc. changed between Q3 2021 and Q4 2021.

All holders in Q4 2021 All holders in Q3 2021

13F holders of AKBA: Q3 2021 compared with Q4 2021
Measure	Q3 2021	Of which not filed for Q4 2021	Q4 2021	Change
Holders	127	1	133	+7
Shares	98.5M	13.1K	96.8M	−1.66M (−1.7%)
Value	$283.7M	$38.0K	$218.7M	−$64.9M (−22.9%)

1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (28)

Institutions that held Akebia Therapeutics, Inc. at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to AKBA in Q4 2021
Institution	Shares	Value	% of portfolio
Millennium Management LLC	1,923,834	$4.35M	0.00%
HRT Financial LP	378,568	$855.0K	0.00%
Wellington Management Group LLP	314,062	$710.0K	0.00%
Allspring Global Investments Holdings, LLC	307,912	$695.0K	0.00%
Caption Management, LLC	210,000	$475.0K	0.03%
Ardent Capital Management, Inc.	168,811	$382.0K	0.25%
Twinbeech Capital LP	148,321	$335.0K	0.02%
Two Sigma Investments, LP	97,174	$220.0K	0.00%
Engineers Gate Manager LP	80,072	$181.0K	0.01%
Dynamic Technology Lab Private Ltd	76,324	$173.0K	0.02%
Simplex Trading, LLC	55,035	$124.0K	0.00%
Alpine Global Management, LLC	54,999	$124.0K	0.02%
Financial Partners Capital Management LLC	27,486	$62.1K	0.01%
XTX Topco Ltd	26,757	$60.0K	0.03%
Squarepoint Ops LLC	26,252	$59.0K	0.00%
Mackenzie Financial Corp	21,280	$48.0K	0.00%
D. E. Shaw & Co., Inc.	14,393	$33.0K	0.00%
Point72 Hong Kong Ltd	13,106	$30.0K	0.00%
Sonora Investment Management Group, LLC	13,085	$30.0K	0.00%
Wolverine Trading, LLC	12,536	$29.0K	0.00%
Tudor Investment Corp Et Al	12,577	$28.0K	0.00%
Sunbelt Securities, Inc.	11,550	$21.0K	0.00%
Dark Forest Capital Management LP	2,004	$5.00K	0.00%
TCI Wealth Advisors, Inc.	1,630	$4.00K	0.00%
TD Waterhouse Canada Inc.	1,291	$3.87K	0.00%
EverSource Wealth Advisors, LLC	1,250	$3.00K	0.00%
Steward Partners Investment Advisory, LLC	374	$1.00K	0.00%
PFS Partners, LLC	187	$423	0.00%

Sold out (21)

Institutions that held Akebia Therapeutics, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.

Institutions that sold out of AKBA in Q4 2021
Institution	Shares, Q3 2021	Value, Q3 2021
PKO Investment Management Joint-Stock Co	622,796	$1.79M
Opaleye Management Inc.	311,300	$897.0K
Walleye Capital LLC	276,260	$796.0K
Gsa Capital Partners LLP	254,376	$733.0K
State of Wisconsin Investment Board	185,734	$535.0K
Jump Financial, LLC	152,300	$439.0K
Maverick Capital LtdSuperinvestorMaverick Capital	105,816	$305.0K
DekaBank Deutsche Girozentrale	102,100	$293.0K
Johnson Investment Counsel Inc	62,460	$180.0K
Walleye Trading LLC	44,901	$129.0K
Oxford Financial Group Ltd	19,006	$55.0K
Kingsview Wealth Management, LLC	10,959	$32.0K
Penserra Capital Management LLC	3,995	$11.0K
O'Shaughnessy Asset Management, LLC	3,379	$10.0K
Cutler Group LP	700	$2.00K
Ellevest, Inc.	757	$2.00K
IFP Advisors, Inc	152	$1.00K
FMR LLC	37	$0
First Horizon Advisors, Inc.	63	$0
Gerber Kawasaki Wealth & Investment Management	50	$0
Meridian Wealth Partners, LLC	266	$0

Not filed for Q4 2021 yet (1)

Institutions that held Akebia Therapeutics, Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding AKBA in Q3 2021 that haven't filed for Q4 2021
Institution	Shares, Q3 2021	Value, Q3 2021
Sonora Investment Management, LLC	13,100	$38.0K